Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Center for Safety Evaluation of Chinese Materia Medica (NCSE) is a leading contract research organization (CRO) based in China, specializing in the non-clinical safety assessment of traditional Chinese medicines (TCM) and natural products. Operating under the China Academy of Chinese Medical Sciences, the center provides comprehensive GLP-compliant toxicology services, including acute, sub-chronic, and chronic toxicity studies, as well as genotoxicity and reproductive toxicity testing. NCSE plays a pivotal role in the modernization of TCM by applying rigorous scientific standards to evaluate the safety profiles of herbal formulations and new drug candidates. The center serves both domestic and international pharmaceutical companies, facilitating the regulatory approval process for innovative therapies derived from natural sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safety Evaluation of Chinese Materia Medica.